
Thursday, May 22, 2025 10:25:00 AM
Recent & Easily Verifiable Facts of KEGS:
KEGS was profitable in the 2nd, 3rd & 4th Quarter of 2024.
KEGS has verifiable assets, 4 properties in New York..
KEGS has 4 active liquor licenses in the State of New York.
KEGS is now delivering beer to 45 states plus DC.
KEGS beer is available to purchase in Canada.
KEGS 1812 beer has won multiple awards in multiple years in multiple competitions.
KEGS recently won New York Amber Ale Brewer of the Year Award.
KEGS has purchased a new restaurant in Watertown, NY now named 1812 On The River.
KEGS has a restaurant in Sackets Harbor, NY now called 1812 on the Lake.
KEGS has its own brewery & bottling processing facility in Watertown that is 13,000 sq feet (different than the restaurant).
KEGS has addressed the $13.7 million in debt and the note holders have tentatively agreed not to convert until market cap reaches $100 million
KEGS has not issued any new shares since March 1st, 2024... NO DILUTION in over 1 year!!! (about 2k shares added presumably for rounding up after reverse split)
Also Breaking News: Brian Mclain has offered to sell, or sold, 100 million shares for $100,000 (pre reverse split) according to a SEC document, form 144/A, filed on 7-29-2024: https://www.otcmarkets.com/filing/html?id=17711190&guid=YBO-knmv0E5eJth
I will let time tell the truth for the shareholders of KEGS!
Good Luck to All Good People Here!
Lets Go KEGS! More Good News!
https://www.otcmarkets.com/stock/KEGS/news
.

Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM